Cytopoint Injection for Dogs: How It Works, Dosage, Benefits, and Side Effects
What Is Cytopoint Injection for Dogs?
Cytopoint is a prescription injectable medication used to control itching associated with allergic and atopic dermatitis in dogs. Its active ingredient, lokivetmab, is a caninized monoclonal antibody designed specifically for dogs. Unlike corticosteroids, antihistamines, or conventional immunosuppressive drugs, Cytopoint works by targeting a specific signaling protein involved in the itch response.
A veterinarian administers Cytopoint as a subcutaneous injection, usually based on the dog’s body weight. One injection can provide relief for approximately four weeks, although the duration varies between individual dogs. Cytopoint controls itching but does not permanently cure the allergy responsible for it.
What Conditions Is Cytopoint Used to Treat?
Cytopoint is primarily used to reduce itching and skin lesions associated with canine atopic dermatitis, a chronic allergic skin condition commonly triggered by environmental allergens such as pollen, house dust mites, mold, and grasses. It may help dogs experiencing persistent scratching, licking, chewing, rubbing, redness, and skin damage related to allergic itching.
Veterinarians may also include Cytopoint in a broader treatment plan for other forms of allergic dermatitis when IL-31-mediated itching is suspected. However, it does not directly eliminate fleas, food allergens, mites, bacterial infections, or yeast infections. These underlying or secondary problems must be identified and treated separately.
Cytopoint should not be used as a substitute for a complete dermatological examination. A dog that continues itching may require parasite control, an elimination diet, skin cytology, infection treatment, or additional allergy management alongside Cytopoint.
How Does Cytopoint Work Against Allergic Itching?
Cytopoint contains lokivetmab, a monoclonal antibody that specifically binds to canine interleukin-31 (IL-31). IL-31 is an important signaling protein involved in transmitting the sensation of itching from the skin to the nervous system. By neutralizing IL-31, Cytopoint interrupts this itch signal and reduces the dog’s urge to scratch, lick, chew, and rub the skin.
Because it targets one specific pathway, Cytopoint has a different mechanism from corticosteroids, ciclosporin, antihistamines, and Janus kinase inhibitors such as Apoquel. It is gradually broken down through normal protein-processing pathways rather than being metabolized like many conventional medications.
Cytopoint controls the sensation of itching, but it does not remove the underlying allergen. Environmental allergy management, parasite prevention, skin-barrier care, diet trials, and treatment of secondary infections may still be required.
How Quickly Does Cytopoint Start Working?
Cytopoint may begin reducing itching within approximately eight hours of administration. Some owners notice improvement during the first day, while other dogs require several days before a clear difference becomes visible.
The response should be evaluated by monitoring scratching, licking, chewing, sleep quality, skin redness, and the healing of damaged areas. Skin lesions may take longer to improve than the itching itself, particularly when bacterial or yeast infections are also present.
If itching remains unchanged or worsens, the veterinarian should reassess the diagnosis rather than simply repeating injections. Fleas, mites, food allergy, skin infection, and nonallergic dermatological diseases can all reduce the apparent response to Cytopoint.
How Long Does a Cytopoint Injection Last?
A Cytopoint injection commonly controls allergic itching for approximately four weeks. Some dogs experience relief for six to eight weeks, while others may begin itching again before the four-week point. The duration depends on the severity of the allergy, allergen exposure, secondary skin disease, and the individual dog’s response.
Cytopoint is generally repeated according to clinical need and the locally approved product label. It does not have to be administered continuously to every dog throughout the year. Dogs with seasonal allergies may only require treatment during high-risk months, whereas those with year-round atopic dermatitis may need regular injections.
Owners should record when itching improves and when it begins to return. If the effect consistently lasts much less than expected, the veterinarian should investigate uncontrolled allergens, fleas, food allergy, bacterial or yeast infections, or another cause of itching.
Cytopoint Dosage for Dogs by Body Weight
Cytopoint dosing is based on the dog’s current body weight and must be calculated and administered by a veterinarian. It is supplied in single-use, 1 mL vials containing 10 mg, 20 mg, 30 mg, or 40 mg of lokivetmab. Multiple vials may be combined for larger dogs.
An important detail is that the approved minimum dose differs between markets:
Regulatory market | Labelled minimum dose | Typical interval |
United States, Canada and some other markets | 2 mg/kg | Every 4–8 weeks as clinically needed |
European Union and some other markets | 1 mg/kg | Once monthly as clinically needed |
The following table illustrates the vial selection used under a 2 mg/kg minimum-dose label:
Dog’s body weight | Cytopoint vial selection | Total lokivetmab |
Under 2.3 kg | Calculated volume from the 10 mg vial | At least 2 mg/kg |
2.3–4.5 kg | One 10 mg vial | 10 mg |
4.6–9.1 kg | One 20 mg vial | 20 mg |
9.2–13.6 kg | One 30 mg vial | 30 mg |
13.7–18.1 kg | One 40 mg vial | 40 mg |
18.2–22.7 kg | One 10 mg + one 40 mg vial | 50 mg |
22.8–27.2 kg | One 20 mg + one 40 mg vial | 60 mg |
27.3–31.7 kg | One 30 mg + one 40 mg vial | 70 mg |
31.8–36.3 kg | Two 40 mg vials | 80 mg |
This table must not be used to select or administer Cytopoint without veterinary supervision. Product concentrations, minimum ages, weight restrictions, approved indications, and dosing instructions can vary by country. The veterinarian should always follow the locally authorized product information.
How Is Cytopoint Administered?
Cytopoint is administered as a subcutaneous injection, usually beneath the skin around the neck or shoulder region. It should be given by a veterinarian or trained veterinary professional after confirming the dog’s weight and selecting the correct vial combination.
The solution is supplied in preservative-free, single-use vials. Once a vial has been opened, the required amount should be used immediately and any remainder discarded according to local regulations. Cytopoint must be stored refrigerated at 2–8°C, protected from light, and never frozen.
Most dogs tolerate the injection well. Sedation is not normally required, and the appointment is generally brief. The veterinarian may monitor the dog after administration, particularly following the first injection or when there is a history of medication reactions.
What Are the Benefits of Cytopoint for Dogs?
One of Cytopoint’s main advantages is its targeted action against IL-31, an important mediator of allergic itching in dogs. Reducing the itch signal can interrupt the itch–scratch cycle, allowing damaged skin to heal and helping lower the risk of further self-inflicted injury.
Potential benefits include:
Relief that may begin within hours or the first few days
Approximately four weeks of itch control from one injection
No need to administer tablets every day
Targeted action without the broad effects of corticosteroids
Normal protein-degradation pathways with limited reliance on liver or kidney metabolism
Potential use alongside other treatments when approved by the veterinarian
Improved sleep, comfort, activity, and overall quality of life
Cytopoint can be particularly useful for dogs that resist oral medication, experience gastrointestinal problems with tablets, or require focused control of allergic itching. However, its benefits vary between dogs, and it should remain part of a broader plan that addresses the underlying allergy and any secondary skin infections.
How Effective Is Cytopoint for Itching and Atopic Dermatitis?
Clinical studies show that Cytopoint can significantly reduce itching and skin lesions in many dogs with atopic dermatitis. Improvement in scratching, licking, chewing, and rubbing may begin within the first day and commonly continues for several weeks.
The response is not identical in every dog. Some achieve strong control after one injection, some have only partial improvement, and others respond poorly because their itching is driven by another condition or by several problems at once. Skin infections, flea allergy, food allergy, mites, and contact irritation can continue causing discomfort even when IL-31 is blocked.
Effectiveness is best assessed using consistent observations rather than relying on a general impression:
Sign to monitor | Evidence of improvement |
Scratching and chewing | Less frequent or intense episodes |
Paw licking | Shorter and less persistent licking |
Sleep | Fewer interruptions caused by itching |
Skin condition | Reduced redness, excoriations, and self-trauma |
Daily behaviour | More comfortable resting, playing, and walking |
Duration of relief | Longer interval before itching returns |
If the first injection produces little or no improvement, the veterinarian may reassess the diagnosis, treat secondary disease, or consider a different antipruritic treatment.
What Are the Most Common Side Effects of Cytopoint?
Most dogs tolerate Cytopoint without noticeable adverse effects. Because lokivetmab is a species-specific monoclonal antibody, it is processed through normal protein-degradation pathways rather than conventional liver metabolism.
Reported adverse events can include:
Some problems observed after treatment may be unrelated to Cytopoint and instead result from the dog’s underlying allergic disease. For example, ear infections, bacterial dermatitis, and yeast overgrowth are common complications of atopic dermatitis itself.
Owners should contact a veterinarian if symptoms are persistent or concerning. Facial swelling, difficulty breathing, collapse, widespread hives, pale gums, unusual bruising, or bleeding require immediate veterinary attention.
Can Cytopoint Cause Serious Adverse Reactions?
Serious reactions to Cytopoint appear to be uncommon, but they remain possible. The most urgent concern is an acute hypersensitivity reaction, which may occur shortly after injection or develop later.
Seek emergency veterinary care if a dog develops:
Swelling of the face, muzzle, eyelids, or throat
Widespread hives or sudden severe itching
Difficulty breathing or noisy respiration
Weakness, collapse, or loss of consciousness
Repeated vomiting or severe diarrhoea
Pale gums, unusual bruising, bleeding, or dark urine
Post-authorisation monitoring has also recorded rare reports of immune-mediated conditions, including haemolytic anaemia and thrombocytopenia. A report following treatment does not necessarily prove that Cytopoint caused the condition, but these signs require prompt investigation.
Any suspected adverse reaction should be documented with the injection date, dose, time of onset, symptoms, other medications, and treatment provided. The veterinarian can report the event to the manufacturer and the appropriate national pharmacovigilance authority.
Is Cytopoint Safe for Puppies, Senior Dogs, and Dogs With Other Conditions?
Cytopoint may be suitable for a wide range of dogs, but approved age and weight restrictions vary between countries. Some labels allow its use in dogs of any age, while others specify a minimum age or body weight. In the European product information, Cytopoint should not be used in dogs weighing less than 3 kg.
Senior age alone does not automatically prevent treatment. Because lokivetmab undergoes normal protein degradation with limited conventional liver or kidney metabolism, it may be considered for some older dogs that cannot tolerate certain oral medications. However, senior dogs should still receive an individual assessment based on their examination, medical history, and concurrent diseases.
Safety has not been fully established during pregnancy, lactation, or breeding, so its use in these animals is generally not recommended unless the veterinarian determines that the expected benefit outweighs the uncertainty.
Before treatment, the veterinarian should be informed about:
Previous allergic reactions to injections or biological medicines
Suspected immune-mediated disease
Pregnancy, lactation, or planned breeding
Current infections or unexplained illness
Cancer or ongoing cancer treatment
All prescription medicines, supplements, and recent vaccines
Cytopoint’s targeted mechanism does not mean that it is risk-free or appropriate for every patient. The locally authorised product label and the dog’s individual clinical condition should guide the decision.
Can Cytopoint Be Used With Other Medications?
Cytopoint is frequently used as one component of a broader allergy-management plan. Clinical field studies have not identified interactions when lokivetmab was administered alongside commonly used veterinary treatments, including antimicrobials, anti-inflammatory medicines, vaccines, and parasite-control products.
Depending on the dog’s condition, a veterinarian may combine Cytopoint with:
Antibiotics or antifungal medication for secondary skin infections
Flea, tick, and mite preventives
Medicated shampoos and topical skin treatments
Allergen-specific immunotherapy
Short-term corticosteroids or Apoquel when additional itch control is required
Ear medications for allergic otitis
Veterinary elimination diets and nutritional supplements
When Cytopoint and a vaccine are administered during the same visit, they should generally be given at different injection sites. Owners should tell the veterinarian about every medication, supplement, injectable product, and recent vaccine before treatment. The absence of widely recognised interactions does not guarantee that every combination is suitable for every dog.
What Should You Do if Cytopoint Does Not Work?
A poor response does not automatically mean that the dose should be increased or the injection repeated early. The veterinarian should first confirm that the dog received the correct weight-based dose and investigate whether another condition is maintaining the itching.
Common reasons for an inadequate response include:
Flea allergy or inconsistent parasite prevention
Bacterial or yeast skin infection
Ear infection
Food allergy
Sarcoptic mange or another parasitic disease
Contact irritation
A nonallergic skin disorder
Severe inflammation requiring additional short-term treatment
Itching driven by pathways other than IL-31
The veterinarian may perform skin cytology, skin scrapings, parasite testing, an elimination diet, or other diagnostic procedures. Photographs and an owner-recorded itch score can help determine whether Cytopoint provided partial relief that was difficult to recognise.
If the diagnosis is correct but the response remains insufficient, alternatives may include Apoquel, ciclosporin, corticosteroids, allergen-specific immunotherapy, topical therapy, or a multimodal treatment plan. Treatment should be changed under veterinary supervision rather than combining or switching medications at home.
Cytopoint vs Apoquel: What Is the Difference?
Cytopoint and Apoquel are both used to control allergic itching in dogs, but they are different types of treatment. Cytopoint is an injectable monoclonal antibody targeting IL-31, whereas Apoquel contains oclacitinib, an oral Janus kinase inhibitor that affects several itch and inflammatory signaling pathways.
Feature | Cytopoint | Apoquel |
Active ingredient | Lokivetmab | Oclacitinib |
Treatment type | Caninized monoclonal antibody | Janus kinase inhibitor |
Administration | Subcutaneous injection | Oral tablet |
Main target | Canine IL-31 | JAK-dependent itch and inflammatory pathways |
Frequency | Commonly every 4–8 weeks, depending on the local label and response | Usually given daily after the initial treatment period |
Onset | May begin within hours | Often begins within hours |
Metabolism | Normal protein-degradation pathways | Metabolized as a conventional medication |
Age restrictions | Vary by country | Commonly restricted to dogs at least 12 months old |
Convenient for | Dogs that resist tablets or need longer-lasting control | Dogs requiring adjustable at-home treatment |
Important concerns | Hypersensitivity and rare reported immune-mediated events | Infection risk, blood changes, and other label-specific precautions |
Neither option is universally better. Cytopoint may be preferred when daily tablets are difficult, conventional drug metabolism is a concern, or highly targeted therapy is desired. Apoquel may be useful when rapid, adjustable control is needed or an injection does not provide adequate relief.
Some dogs may receive both medicines for a limited period under veterinary direction, particularly during severe allergic flares. They should not be combined without a clinical reason and professional supervision.
How Often Can a Dog Receive Cytopoint?
Cytopoint is commonly administered approximately once every four weeks, but the permitted and clinically appropriate interval depends on the country-specific label and the individual dog’s response. In some markets, repeat treatment every four to eight weeks is authorised as needed.
The next injection should be based on the return of clinically meaningful itching rather than automatically following a fixed calendar in every patient. Owners can record weekly itch scores to help determine the duration of benefit.
Observed response | Possible veterinary approach |
Good control lasting about four weeks | Repeat near the four-week point if needed |
Relief lasting six to eight weeks | Extend the interval based on clinical response |
Seasonal itching | Treat during the relevant allergy season |
Relief lasting less than expected | Reassess infection, parasites, diagnosis, and dose |
No meaningful improvement | Consider additional testing or another treatment |
Repeated Cytopoint injections may be used for long-term management when they remain effective and well tolerated. Nevertheless, periodic veterinary reassessment is important because allergy severity, body weight, secondary infections, and treatment needs can change over time. Cytopoint injection for dogs.
Frequently Asked Questions About Cytopoint Injection for Dogs
Is Cytopoint a steroid?
No. Cytopoint is not a corticosteroid or a conventional immunosuppressive drug. It contains lokivetmab, a caninized monoclonal antibody that neutralizes canine IL-31, an important signaling protein involved in allergic itching.
Is Cytopoint an antihistamine?
No. Antihistamines block the effects of histamine, whereas Cytopoint specifically targets IL-31. This difference helps explain why Cytopoint may reduce itching in dogs that have not responded well to antihistamines.
How quickly does Cytopoint begin working?
Cytopoint may begin reducing itching within approximately eight hours. Some dogs show visible improvement during the first day, while others need several days before owners notice a meaningful change.
How long does Cytopoint remain effective?
One injection commonly provides relief for approximately four weeks. Some dogs experience benefits for six to eight weeks, while the effect may be shorter in others. The injection interval should be determined according to the dog’s response and local product instructions.
Can Cytopoint permanently cure a dog’s allergy?
No. Cytopoint controls an important itch pathway but does not eliminate the underlying allergy. Environmental allergen management, parasite prevention, diet trials, skin care, and treatment of secondary infections may still be required.
Can Cytopoint be given to a dog with a skin infection?
Cytopoint may be used while a bacterial or yeast infection is treated, provided the veterinarian considers it appropriate. However, Cytopoint does not kill bacteria or fungi, so the infection requires separate treatment.
Does a dog need blood tests before receiving Cytopoint?
Routine blood testing is not universally required solely because a dog is receiving Cytopoint. A veterinarian may still recommend testing for senior dogs, medically complex patients, or dogs showing signs of another illness.
Can dogs receive Cytopoint for the rest of their lives?
Repeated long-term treatment may be considered when Cytopoint remains effective and well tolerated. The dog should still receive periodic veterinary examinations to reassess its weight, skin condition, allergy triggers, infections, and continuing need for treatment.
Can Cytopoint stop working over time?
Some dogs may experience a reduced or shorter response over time. This can result from changing allergen exposure, secondary infection, progression of skin disease, an incorrect diagnosis, or, less commonly, antibodies directed against the medication. Veterinary reassessment is needed before changing the dose or interval.
What should owners do after a Cytopoint injection?
Owners should monitor itching, skin condition, appetite, energy, vomiting, diarrhoea, injection-site discomfort, facial swelling, and breathing. A weekly itch record can help measure effectiveness. Facial swelling, difficulty breathing, collapse, pale gums, or unusual bleeding require immediate veterinary care.
Sources
Official source | URL |
European Medicines Agency — Cytopoint Product Information | |
European Medicines Agency — First Monoclonal Antibody in Veterinary Medicine | |
USDA Animal and Plant Health Inspection Service — Cytopoint Product Summary | |
USDA APHIS — Reporting Adverse Events for Veterinary Biological Products | |
UK Veterinary Medicines Directorate — Cytopoint 10 mg/mL Product Information | |
Zoetis US — Cytopoint for Veterinary Professionals | |
Zoetis Canada — Cytopoint Dosage and Administration | |
Zoetis Singapore — Cytopoint Dosing and Storage | |
Mersin Vetlife Veterinary Clinic |
Comments